Published on 20 Jan 2023 on Zacks via Yahoo Finance
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
NeuBase Therapeutics, Inc. NBSE: This preclinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
NeuBase Therapeutics, Inc. Price and Consensus